Periodical
Addition of a tumor-targeting antibody-interleukin-2 fusion enhances the anti-cancer efficacy of FAP-directed radioligand therapy in mice
| العنوان: | Addition of a tumor-targeting antibody-interleukin-2 fusion enhances the anti-cancer efficacy of FAP-directed radioligand therapy in mice |
|---|---|
| المؤلفون: | Dorten, P., Gierse, F., Claesener, M., Hermann, S., Neri, D., Cazzamalli, S., Schäfers, M., Backhaus, P. |
| المصدر: | Nuklearmedizin. Nuclear medicine; April 2023, Vol. 62 Issue: 2 |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 00295566 |
|---|---|
| DOI: | 10.1055/s-0043-1766145 |